Stock Events

Alnylam Pharmaceuticals (ALNY) Q2 2024 Earnings

2MayConfirmed
Q3 2023
Q4 2023
Q1 2024
Q2 2024
-2.21
-0.89
0.42
1.74

Details

Expected EPS
-1.116022
Actual EPS
-0.52
Surprise EPS
0.6
Surprise Percent
+53.41%

Description

Alnylam Pharmaceuticals (ALNY) has reported earnings of -0.52 per share for Q2 2024.

0 Comments

Share your thoughts